New Director of Medical Writing

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
kmall
Posts: 753
Joined: Thu Mar 21, 2019 3:57 pm

New Director of Medical Writing

Post by kmall » Fri Nov 19, 2021 7:27 am

Annat Ikin - Director Medical Writing, Geron Corporation

Hired Nov 2021 - 11/18/2021 - Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly hired employee in connection with commencement of employment with the Company. It is most likely that Annat Ikin is this employee.

Prior to Geron, Annat was employed for 14 years by Celgene as a Principal and Senior Medical Writer. Annat's background includes a Postdoctoral at Rockefeller University in NYC, Mount Sinai School of Medicine, Thomas Jefferson University and Tel Aviv University with a PhD in Biochemistry.

"Medical writing for the pharmaceutical industry can be classified as either regulatory medical writing or educational medical writing.

Regulatory medical writing means creating the documentation that regulatory agencies require in the approval process for drugs, devices and biologics. Regulatory documents can be huge and are formulaic. They include clinical study protocols, clinical study reports, patient informed consent forms, investigator brochures and summary documents (e.g. in Common Technical Document [CTD] format) that summarize and discuss the data a company gathers in the course of developing a medical product."

Medical Writer: https://en.m.wikipedia.org/wiki/Medical_writing


** Geron employee update:

As of Nov 2021, Veronica Backlund - Senior Regulatory Affairs Manager at Geron Corporation has left Geron after 11 months of employment. Veronica is now: Senior Manager, Regulatory Affairs, Rare Diseases at Chiesi USA, INC. -Kmall

Post Reply